DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Schlumberger M, Tahara M, Wirth LJ, Robinson B, Brose MS, Elisei R, Habra MA, Newbold K, Shah MH, Hoff AO, Gianoukakis AG, Kiyota N, Taylor MH, Kim SB, Krzyzanowska MK, Dutcus CE, de las Heras B, Zhu J, Sherman SI.
Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.
N Eng J Med 2015;
372: 621-630
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.